痴呆症护理研究和心理社会因素
Emily E Munn1, Anna Montelongo2, Viraj K Patel2
1Indiana University Bloomington, Bloomington, IN, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
对阿尔茨海默病 (AD) 的干预措施对患有唐氏综合征 (DS) 的人来说是有前途的. 药理学,运动和认知训练方法可以改善这一群体的认知和行为结果.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 唐氏综合征 (DS) 是阿尔茨海默氏症 (AD) 的重要遗传风险因素.
- 在40-54岁的DS个体中,AD症状发生率急剧上升,从8%到80%.
- 关于特别针对DS患者的AD预防和治疗的研究有限.
研究的目的:
- 系统地审查和元分析预防和治疗AD患者的干预措施的有效性.
- 评估药理和非药理干预措施.
主要方法:
- 在2023年12月1日之前发表的英语,同行评审文章的系统审查和元分析.
- 包括的研究集中在18-69岁的成年人身上,他们有DS和AD相关的认知/行为结果.
- 选了781个记录,其中25篇文章 (1,417名参与者) 符合纳入标准.
主要成果:
- 分析了四种干预类型:药物 (18项研究),运动 (5),环境 (1) 和认知训练 (1).
- 总的来说,干预措施显著改善了认知和行为结果 (p < 0.0001).
- 在干预效应中观察到很高的异质性 (I2 = 93.8%).
结论:
- 干预措施在患有DS的个体中证明了AD的有效性.
- 特定的药理学药物 (多内佩齐尔,抗抑郁药,EGCG,西姆瓦斯塔丁,尼古丁) 显示出广泛的益处.
- 运动和认知训练在这个人群中为减少AD症状提供了有希望的策略.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
